Search results
Jul 7, 2014 · View Hari Bhaskaran’s profile on LinkedIn, a professional community of 1 billion members. Experience: Cisterna Biologics · Education: The University of Texas at Austin · Location: San Diego...
- 500+
- Cisterna Biologics
- 1.1K
Nonspecific binding to structured RNA and preferential unwinding of an exposed helix by the CYT-19 protein, a DEAD-box RNA chaperone. P Tijerina, H Bhaskaran, R Russell. Proceedings of the...
Welcome to YC, Hari Bhaskaran and team at Cisterna Biologics! Cisterna uses proprietary technologies to build the next generation of mRNA, free of impurities, at a fraction of the price.
Information on valuation, funding, cap tables, investors, and executives for Cisterna Biologics. Use the PitchBook Platform to explore the full profile.
- Founder & Chief Executive Officer
Hari BHASKARAN, Scientist / technology developer | Cited by 651 | | Read 19 publications | Contact Hari BHASKARAN
Hari Bhaskaran, Founder. Hari Bhaskaran's journey with RNAs started with ribozymes (catalytic RNAs) almost 20 years ago in the labs of Rick Russell at UT Austin. His PhD work was focused on mechanistic understanding of RNA folding, culminating in a seminal publication in Nature (see Bhaskaran and Russell, 2007).
Founders Hari Bhaskaran. Operating Status Active. Last Funding Type Pre-Seed. Legal Name Cisterna Biologics, Inc. Company Type For Profit. Contact Email founders@cisternabx.com. Phone Number +1 619-330-9301. Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics.
